OraSure Technologies Inc

Financials

Cash from operating activities 109 K-19.73 M-10.22 M-10.07 M-9 M -49.02 M Cash from investing activities -5.49 M370 K-1.94 M-821 K-4.42 M -6.81 M Cash from financing activities -111 K-953 K-5.8 M-5.08 M-5.11 M -16.94 M Free cash flow -347 K-20.15 M-12.16 M-10.99 M-9.92 M -53.22 M

OraSure Technologies, Inc. is a Bethlehem, Pennsylvania–based company in the medical device industry. Their products include diagnostic testing kits. The company had recently developed OraQuick testing kit, the first over-the-counter home HIV test.

OSUR

Financials

OraSure Technologies Inc

News

Altai Capital pushes for board seats at OraSure Technologies

OraSure CFO McGrath buys $66k in OSUR stock

OraSure Technologies (OSUR) president buys $66k in shares

OraSure Technologies, Inc. (OSUR) Q4 2025 Earnings Call Transcript

OraSure earnings matched, revenue fell short of estimates

InfuSystems Holdings, Inc. (INFU) Q4 Earnings Beat Estimates

OraSure’s HIV self-test receives Health Canada license

Phibro Animal Health (PAHC) Q2 Earnings and Revenues Surpass Estimates

Altai Capital nominates two directors for OraSure Technologies board

Altai Capital nominates two directors to OraSure board amid concerns

OraSure Files for FDA Review of Molecular Self-Test & Colli-Pee Device

OraSure submits FDA applications for rapid STI test and collection device